TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
7.46
-0.14 (-1.84%)
Jun 4, 2026, 1:53 PM CST
TaiwanJ Pharmaceuticals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 67.82 | 47.61 | 58.83 | 60.69 | 82.88 |
Short-Term Investments | - | 40 | - | - | - |
Cash & Short-Term Investments | 67.82 | 87.61 | 58.83 | 60.69 | 82.88 |
Cash Growth | -22.58% | 48.92% | -3.06% | -26.77% | -11.31% |
Accounts Receivable | - | - | - | 4.61 | - |
Other Receivables | 5.37 | 5.31 | 4.85 | 5.68 | 5.26 |
Receivables | 5.37 | 5.31 | 4.85 | 10.29 | 5.26 |
Prepaid Expenses | 0.23 | 0.27 | 0.18 | 0.17 | 0.25 |
Other Current Assets | - | - | 0.23 | 0.02 | 0 |
Total Current Assets | 73.42 | 93.18 | 64.09 | 71.17 | 88.39 |
Property, Plant & Equipment | 2.25 | 1.51 | 3.04 | 3.03 | 0.32 |
Other Intangible Assets | - | - | 0.36 | 0.94 | 76.8 |
Other Long-Term Assets | 1.58 | 6.08 | 6.08 | 4.65 | 4.83 |
Total Assets | 77.25 | 100.77 | 73.56 | 79.79 | 170.33 |
Accrued Expenses | 3.46 | 4.15 | 4.5 | 4.45 | 5.16 |
Current Portion of Leases | 0.78 | 0.47 | 0.7 | 0.69 | 0.33 |
Other Current Liabilities | 1.08 | 1.09 | 0.95 | 1.88 | 1.36 |
Total Current Liabilities | 5.32 | 5.71 | 6.15 | 7.02 | 6.85 |
Long-Term Leases | 1.01 | - | 0.47 | 1.17 | - |
Total Liabilities | 6.33 | 5.71 | 6.62 | 8.19 | 6.85 |
Common Stock | 801.22 | 801.22 | 751.22 | 751.22 | 751.22 |
Additional Paid-In Capital | 2.64 | 2.43 | 1.97 | 0.59 | - |
Retained Earnings | -732.94 | -708.59 | -686.25 | -680.2 | -587.74 |
Shareholders' Equity | 70.92 | 95.05 | 66.94 | 71.6 | 163.48 |
Total Liabilities & Equity | 77.25 | 100.77 | 73.56 | 79.79 | 170.33 |
Total Debt | 1.79 | 0.47 | 1.17 | 1.86 | 0.33 |
Net Cash (Debt) | 66.04 | 87.14 | 57.66 | 58.83 | 82.55 |
Net Cash Growth | -24.21% | 51.12% | -1.99% | -28.73% | -10.81% |
Net Cash Per Share | 0.82 | 1.14 | 0.77 | 0.78 | 1.10 |
Filing Date Shares Outstanding | 80.12 | 80.12 | 75.12 | 75.12 | 75.12 |
Total Common Shares Outstanding | 80.12 | 80.12 | 75.12 | 75.12 | 75.12 |
Working Capital | 68.11 | 87.47 | 57.94 | 64.16 | 81.54 |
Book Value Per Share | 0.89 | 1.19 | 0.89 | 0.95 | 2.18 |
Tangible Book Value | 70.92 | 95.05 | 66.58 | 70.67 | 86.69 |
Tangible Book Value Per Share | 0.89 | 1.19 | 0.89 | 0.94 | 1.15 |
Machinery | 4.14 | 3.86 | 3.86 | 2.83 | 2.83 |
Leasehold Improvements | 1.64 | 1.64 | 1.64 | 1.23 | 2.56 |